Health Catalyst (NASDAQ:HCAT) Given “In-Line” Rating at Evercore ISI

Evercore ISI reissued their in-line rating on shares of Health Catalyst (NASDAQ:HCAT) in a report published on Wednesday morning, Marketbeat reports. They currently have a $4.00 price objective on the stock, down from their previous price objective of $6.00.

A number of other research firms have also recently weighed in on HCAT. Citigroup lowered their price target on shares of Health Catalyst from $10.50 to $10.00 and set a “buy” rating on the stock in a report on Friday, January 10th. Stephens decreased their price objective on Health Catalyst from $7.00 to $5.00 and set an “equal weight” rating for the company in a report on Thursday, March 6th. Stifel Nicolaus dropped their target price on Health Catalyst from $10.00 to $5.00 and set a “hold” rating on the stock in a research note on Thursday, February 27th. Royal Bank of Canada decreased their price target on Health Catalyst from $7.00 to $6.00 and set a “sector perform” rating for the company in a research note on Thursday, February 27th. Finally, Wells Fargo & Company dropped their price target on Health Catalyst from $13.00 to $10.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 21st. Three investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, Health Catalyst currently has a consensus rating of “Moderate Buy” and a consensus price target of $8.73.

Health Catalyst Stock Down 6.5 %

NASDAQ:HCAT traded down $0.26 during trading hours on Wednesday, reaching $3.76. The company’s stock had a trading volume of 239,719 shares, compared to its average volume of 616,643. The stock has a 50 day moving average price of $4.72 and a two-hundred day moving average price of $6.57. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.41 and a current ratio of 1.41. The company has a market capitalization of $263.92 million, a P/E ratio of -2.78 and a beta of 1.43. Health Catalyst has a 12 month low of $3.60 and a 12 month high of $9.24.

Insider Activity at Health Catalyst

In other Health Catalyst news, COO Daniel Lesueur sold 5,209 shares of the company’s stock in a transaction dated Wednesday, February 5th. The shares were sold at an average price of $5.76, for a total value of $30,003.84. Following the transaction, the chief operating officer now owns 86,044 shares of the company’s stock, valued at $495,613.44. This represents a 5.71 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Linda Llewelyn sold 6,442 shares of Health Catalyst stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $5.80, for a total value of $37,363.60. Following the completion of the sale, the insider now directly owns 92,260 shares of the company’s stock, valued at $535,108. The trade was a 6.53 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 54,030 shares of company stock worth $263,269 in the last 90 days. Corporate insiders own 2.50% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Centiva Capital LP acquired a new stake in shares of Health Catalyst during the third quarter worth about $324,000. Quadrature Capital Ltd purchased a new position in shares of Health Catalyst during the third quarter worth about $84,000. State Street Corp increased its position in Health Catalyst by 2.5% in the 3rd quarter. State Street Corp now owns 1,163,754 shares of the company’s stock valued at $9,473,000 after acquiring an additional 28,251 shares during the period. Geode Capital Management LLC raised its stake in Health Catalyst by 4.9% during the 3rd quarter. Geode Capital Management LLC now owns 1,443,036 shares of the company’s stock valued at $11,749,000 after acquiring an additional 66,896 shares during the last quarter. Finally, Franklin Resources Inc. lifted its position in Health Catalyst by 5.8% during the 3rd quarter. Franklin Resources Inc. now owns 104,141 shares of the company’s stock worth $857,000 after acquiring an additional 5,687 shares during the period. Institutional investors and hedge funds own 85.00% of the company’s stock.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.